Table 1.
Treatment outcome definitions.
Table 2.
Baseline demographic characteristics of MDR/RR-TB patients initiated on treatment during 2010 to 2015 in Zimbabwe.
Table 3.
Clinical characteristics of MDR/RR-TB patients at baseline and/or during MDR-TB initiated on treatment in Zimbabwe, 2010–2015.
Table 4.
Distribution and type of severe adverse events encountered during MDR-TB treatment among MDR/RR-TB patients in Zimbabwe, 2010–2015.
Fig 1.
Treatment outcomes among MDR/RR TB patients registered in Zimbabwe between 2010 and 2015, stratified by year of treatment commencement.
Table 5.
Programmatic treatment outcomes of MDR/RR-TB patients initiated on treatment during 2010 to 2015 in Zimbabwe.
Table 6.
Sociodemographic and clinical characteristics associated with unfavourable outcomes among MDR/RR-TB patients initiated on treatment during 2010 to 2015 in Zimbabwe.